EQL Pharma is a generics- and speciality pharma company, dedicated to providing cost efficient pharmaceuticals for the Nordic markets. This is accomplished with the highest quality standards and streamlined logistic solutions.
EQL Pharma signs agreement with leading generic company
EQL estimates that the profitability will be similar, whether EQL Pharma sells on its own or through the partner. However, other benefits such as reduced working capital need and a higher penetration, speaks in favour of the cooperation. The financial…
Positive news concerning the pharmaceutical product Eletriptan EQL Pharma
The pharmaceutical product Eletriptan EQL Pharma was approved Monday within the framework of a decentralized procedure (a common approval procedure used when more than one country is involved). National approvals for Sweden and Denmark are expected within approximately a month.…
Zonisamid EQL Pharma launched in Denmark
Zonisamide EQL Pharma is an antiepileptic, used for the treatment of epilepsy. The original is called Zonegran (Eisai Limited).The total turnover of Zonisamid in Denmark is approximately SEK 10 million annually. Currently the original and 3 competitors are on the…
- View all press releases